L-Glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 172 (1), 143-148
- https://doi.org/10.1016/s0006-291x(05)80184-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRFEuropean Journal of Pharmacology, 1990
- Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxideNature, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990
- The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factorEuropean Journal of Pharmacology, 1990
- l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitroBritish Journal of Pharmacology, 1990
- Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1989
- Endothelin-1 and Endothelin-3 Release EDRF from Isolated Perfused Arterial Vessels of the Rat and RabbitJournal of Cardiovascular Pharmacology, 1989
- Arginine is a physiological precursor of endothelium-derived nitric oxideEuropean Journal of Pharmacology, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOODBritish Journal of Pharmacology and Chemotherapy, 1964